National Access Cannabis Corp. to Participate at the Eight Capital & Cassels Global Cannabis Conference on Thursday September 19, 2019 and Announces Change to Management Team

TORONTO, Sept. 17, 2019 /CNW/ - National Access Cannabis Corp. ("NAC" or "the Company") (TSXV: META), today announced that it is scheduled to participate in a panel at the Eight Capital & Cassels Global Cannabis Conference being held on September 19, 2019, at the Shangri-La Hotel in Toronto.

Panel details are as follows:

Presenter:	Mark Goliger, Chief Executive Officer
Panel Title:	Delivering the Customer Experience
Date:	Thursday, September 19, 2019
Time:	11:00-11:30 AM EST
Location:	Shangri-La Hotel Toronto; Queen's Park Ballroom

Representatives of the Company would be pleased to meet with institutional investors throughout the duration of the conference.

Change to Management Team

NAC today also announced that Lori Bailey, Senior Vice-President of Retail, is no longer with the Company.

About National Access Cannabis Corp.
NAC is Canada's largest recreational cannabis retailer¹. With a portfolio of 35 licensed retail locations nationwide, NAC is the leader in secure, safe and responsible access to legal recreational cannabis in Canada. Through its Canada-wide network of Meta Cannabis Supply Co.™ and NewLeaf Cannabis™ recreational cannabis retail stores and NAC Medical's cannabis clinics and pharmacy partnerships, NAC enables the public and registered patients to gain knowledgeable access to Canada's network of authorized Licensed Producers of cannabis. NAC is listed on the TSX Venture Exchange under the symbol (TSXV: META).

¹Canaccord Genuity, Canadian Cannabis Report, July 17, 2019

For more information, visit:
www.nationalaccesscannabis.com
www.metacannabis.com
www.newleafcannabis.ca
www.nacbio.com
www.nacmedical.com  

Cautionary Statements

This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words "expect", "anticipate", "continue", "estimate", "objective", "ongoing", "may", "will", "project", "should", "believe", "plans", "intends" and similar expressions are intended to identify forward looking statements or information. Forward-looking statements and information in this news release includes, but is not limited to the Company's attendance at the Eight Capital & Cassels Global Cannabis Conference. Although the Company believes that the expectations and assumptions on which the forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company cannot give any assurance that they will prove to be correct. Since forward-looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results and developments may differ materially from those that are currently contemplated by these statements depending on, among other things, future legislative and regulatory developments involving cannabis; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; general business, economic, competitive, political and social uncertainties; the competitive conditions of the cannabis industry; the competitive and business strategies of the Company; the labour market generally and the ability to access, hire and retain employees; and the recreational and medical cannabis industry in Canada generally. The Company cautions that the foregoing list of risks and uncertainties is not exhaustive. The forward-looking statements and information contained in this news release are made as of the date hereof and the Company undertakes no obligation to update publicly or revise any forward-looking statement or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE National Access Cannabis Corp.

National Access Cannabis: Mark Goliger, Chief Executive Officer, National Access Cannabis, Tel: [phone], [email protected]; Investor Relations: Emily Gibbs, LodeRock Advisors Inc., Tel: [phone], [email protected]; Media Inquiries: Jessica Patriquin, Tel: [phone] x 230, Cell: 416-995-8496, [email protected]